Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Single-stage PFC converter with constant voltage and constant current
Image processor
Secure service for enabling communication for calling party when communication service for called party is suspended
Systems and methods to provide communication history for communication devices
Gathering user feedback in web applications
Synthesis of 8-amino boron dipyrromethenes having blue fluorescence
Analyte assaying by means of immunochromatography with lateral migration
  Randomly Featured Patents
Wood splitting device
Method for forming damascene structure utilizing planarizing material coupled with compressive diffusion barrier material
Triterpenes for modulating gene expression and cell membrane, and as antiprotozoal agents
Thermoformed platform having a communications device
Swim goggles
Catalyst, and processes for dehydrogenating dehydrogenatable hydrocarbons
Flotation mattress pad having a cover with pad retaining straps
Optical switch system and apparatus
Microwave cooking vessel with removable food supports
Zn-Al-Mg-Si-alloy plated steel product having excellent corrosion resistance and method for preparing the same